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Abstract
Background:  Recombinant proteins expressed in Escherichia coli vectors are generally
contaminated with endotoxin. In this study, we evaluated the ability of Polymyxin B to neutralize
the effect of LPS present as contaminant on Schistosoma mansoni recombinant proteins produced
in  E. coli in inducing TNF-α and IL-10. Peripheral blood mononuclear cells from individuals
chronically infected with S. mansoni were stimulated in vitro with recombinant Sm22.6, Sm14 and
P24 antigens (10 μg/mL) in the presence of Polymyxin B (10 μg/mL).
Results: The levels of cytokines were measured using ELISA. There was greater than 90 %
reduction (p < 0.05) in the levels of TNF-α and IL-10 when Polymyxin B was added to the cultures
stimulated with LPS. In cultures stimulated with S. mansoni recombinant proteins in the presence
of Polymyxin B, a reduction in the levels of TNF-α and IL-10 was also observed. However, the
percentage of reduction was lower when compared to the cultures stimulated with LPS, probably
because these proteins are able to induce the production of these cytokines by themselves.
Conclusion: This study showed that Polymyxin B was able to neutralize the effect of endotoxin,
as contaminant in S. mansoni recombinant antigens produced in E. coli, in inducing TNF-α and IL-10
production.
Background
Recombinant proteins represent an important tool in the
field of immunology research and have been used to
understand pathogenesis and host susceptibility and may
serve as components for vaccines. In general these pro-
teins augment the specificity of diagnostic tests since they
are specific peptides with known sequences.
The production of most recombinant proteins is achieved
through cloning into Escherichia coli vectors containing
cDNA coding for the desired protein. A common limita-
tion to this process is the contamination of recombinant
protein with endotoxin [1]. Endotoxins are a set of com-
plex lipopolysaccharides (LPS) which are the integral
component of gram-negative bacteria such as E. coli. The
LPS is a component of the pathogen associated molecular
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pattern (PAMPs) which bind to multiple receptors, such
as LPS binding protein (LBP), macrophage receptor
(CD14) and Toll like receptor-4 (TLR-4) [2,3]. This results
in activation of intracellular signalling pathways and pro-
duction of pro-inflammatory cytokine such as TNF-α, IL-
1 and IL-6 [4,5]. In patients infected with gram-negative
bacteria, high levels of TNF-α lead to an endotoxemic syn-
drome or septic shock, which can result in intravascular
disseminated coagulation, heart failure and death [6]. It
has been described that at a low dose, LPS is able to
induce both TNF-α and IL-10 production [7]. IL-10 is an
anti-inflammatory cytokine able to down-modulate TNF-
α production [8,9]. After the process of recombinant pro-
tein production in E. coli, the protein is purified using dif-
ferent techniques. For example, proteins associated with
6-His tag fusion at the N-terminus are purified using an
HPLC Ni2+ charged resin (GE Health care). Proteins are
eluted by imidazol in the refolding buffer. This is a very
common method to obtain purified proteins, but they are
almost always contaminated with certain amount of LPS.
For instance, the commercially available recombinant
proteins rHsp70 and rHsp60 induce TNF-α production by
macrophages due to LPS contamination [8,9].
There are some methods to clean proteins from LPS con-
tamination with limited efficacy [1]. The natural peptide,
Polymyxin B (PMB), is a potent antibiotic that binds to
and neutralizes LPS. It is a decapeptide cyclic cationic anti-
biotic containing lipophilic and hydrophilic groupment
(lipophobic) that binds to lipid A, the major component
of the endotoxin. The plasmatic half-life of PMB is 6
hours, but it can be detected in blood 8 to 12 hours after
use. Studies have demonstrated that PMB can protect ani-
mals from the toxic effects of endotoxin [10,11]. In this
study, we evaluated the ability of Polymyxin B to neutral-
ize the effect of LPS present as contaminant in Schistosoma
mansoni  recombinant proteins produced in E. coli in
inducing TNF-α and IL-10 production in peripheral blood
mononuclear cells (PBMC) from individuals infected
with S. mansoni.
Results
The kinetics of LPS-induced cytokine production was eval-
uated in PBMC cultures of individuals infected with S.
mansoni incubated for 6, 12, 24 and 48 h. The concentra-
tion of LPS used in the cultures was similar to what was
detected in the S. mansoni recombinant proteins used in
this study (Table 1). We observed high levels of TNF-α in
supernatants of LPS-stimulated cultures incubated for 6 h
(758 ± 815 pg/mL), and the levels increased at 12 h and
24 h, 1482 ± 1489 and 2123 ± 1080 pg/mL, respectively
(Figure 1). There was a decrease in TNF-α production after
48 h of culture, which represented a 40.4 % reduction. In
contrast, IL-10 production began after 12 h of culture
(314 ± 341 pg/mL), and reached a higher concentration at
24 h of culture (435 ± 395 pg/mL) (Figure 1).
Since it is well known that LPS induces high levels of TNF-
α [7], we evaluated the role of PMB blockage on the syn-
thesis of this cytokine in cultures stimulated with LPS. The
production of TNF-α in 6, 12, 24 and 48 h-cultures stim-
ulated with LPS in the presence or absence of PMB is
shown in Figure 2. Compared to cultures without PMB,
there was a reduction in the levels of TNF-α by addition of
this antibiotic to the cultures at all time-points evaluated.
The mean levels of TNF-α decreased from 758 ± 815 pg/
mL to 15.6 ± 9.0 pg/mL at 6 h-culture (97.9% of reduc-
tion, p = 0.03) and from 1481 ± 1489 pg/mL to 108 ± 175
pg/mL (92.7 % of reduction, p = 0.03), 2123 ± 1080 pg/
mL to 15.6 ± 0 pg/mL (99.3 % of reduction, p = 0.06) and
1264 ± 1143 pg/mL to 60 ± 104 pg/mL (95.2 % of reduc-
tion, p = 0.03) at 12, 24 and 48 h-culture, respectively.
Polymyxin B was used at a final concentration of 30 and
60 μg/mL in cultures and similar levels of reduction in
cytokine production were observed (data not shown).
Therefore, we decided to use the lower concentration of
PMB (30 μg/mL). We also tested the viability of cells in
cultures with Polymyxin B using trypan blue stain and we
observed that, independent of the presence of PMB, the
viability of the cells was about 98 % (data not shown).
The cytokine production induced by S. mansoni recom-
binant proteins P24, Sm14 and Sm22.6 in the presence or
absence of Polymyxin B is shown in Figure 3 (A, B and C,
respectively). All recombinant proteins used in this study
induced high levels of TNF-α in 6, 12, 24 and 48 h cul-
tures (mean levels higher than 2000 pg/mL), with the
exception to Sm22.6 in 48 h culture (mean level 710 ±
1193 pg/mL). With the addition of PMB to the cultures,
Table 1: Levels of LPS present as contaminant in S. mansoni recombinant proteins P24, Sm14 and Sm22.6
S. mansoni Recombinant Protein (1 mg) LPS
(EU/mL) (ng/mL)
P24 1.35 0.135
Sm14 2.10 0.210
Sm22.6 1.32 0.132Microbial Cell Factories 2007, 6:1 http://www.microbialcellfactories.com/content/6/1/1
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there was a reduction in the mean levels of TNF-α, mainly
when Sm14 and Sm22.6 were used.
Figure 4A, 4B and 4C show the levels of IL-10 production
in cultures stimulated with P24, Sm14 and Sm22.6,
respectively. High levels of IL-10 were observed in 24 and
48 h cultures to all three antigens evaluated (above 500
pg/mL). After the addition of PMB, there was higher
reduction in IL-l0 production (over 60%) when the cul-
tures were stimulated with Sm14 and Sm22.6 at every
time-point of cultures evaluated.
Levels of TNF-α and IL-10 were below the detection limit
in unstimulated cultures, and these cytokines were
detected in high levels in the supernatants of PBMC cul-
tures stimulated with PHA (data not shown).
Discussion
Contamination of recombinant proteins cloned in gram-
negative bacteria with endotoxin represents a serious
problem in laboratory research. In this study, we evalu-
ated a method to neutralize endotoxin as a contaminant
of recombinant antigens by reducing production of TNF-
α and IL-10 in vitro. Polymyxin B is an antibiotic used to
prevent septic shock [6,12] and it has been used to neu-
tralize LPS-induced TNF-α production in vitro [13]. We
used three S. mansoni recombinant proteins produced in
E. coli to test the effect of Polymyxin B on TNF-α and IL-
10 production. Before the evaluation of the induction of
cytokine production by the recombinant proteins we eval-
uated the kinetics of TNF-α and IL-10 synthesis in cultures
stimulated with LPS, in concentrations similar to what
was detected in recombinant proteins. We observed that
while TNF-α was produced at high levels in 6 h of cultures
and increased after 12 h, IL-10 production started after 12
h of culture and the levels were lower than the levels of
TNF-α. IL-10 seems to be produced in response to TNF-α,
appearing after 12 h of culture probably to modulate TNF-
α production. IL-10 is an anti-inflammatory cytokine,
which can modulate TNF-α production and it has been
shown that IL-10 down-regulates TNF-α production in
models of septic shock [12,14].
The use of Polymyxin B in cultures stimulated with LPS
completely abrogated TNF-α production. To a less extent,
PMB also down-modulated the TNF-α and IL-10 produc-
tion when S. mansoni recombinant proteins were used.
Therefore, we concluded that these proteins are able to
induce these cytokine productions by themselves.
Supporting our results, addition of Polymyxin B to
murine macrophage cultures stimulated with recom-
binant proteins produced in bacteria resulted in down-
modulation of TNF-α production [8,9]. However, few
studies have used Polymyxin B to neutralize TNF-α pro-
duction in cultures of human cells stimulated with recom-
binant proteins, and they have not tested the ability of
PMB in blocking LPS-induced IL-10 production.
Conclusion
Many studies have evaluated the immune response
induced by recombinant proteins produced in bacteria,
few remark on the potential influence of contamination
with endotoxin. Here we demonstrated that proteins
expressed in bacteria are able to induce high levels of TNF-
α and IL-10 production and we demonstrated that Poly-
myxin B prevented the LPS-induced cytokine production.
These results support the use of Polymyxin B in laboratory
research that uses recombinant antigens produced in E.
Effect of Polymyxin B on LPS-induced cytokine production in  vitro Figure 2
Effect of Polymyxin B on LPS-induced cytokine pro-
duction in vitro. This figure shows the effect of the addition 
of Polymyxin B to the PBMC culture of individuals chronically 
infected with S. mansoni (n = 06) on LPS-induced TNF-α. LPS 
was used in the concentration of 0.14 ng/mL and Polymyxin B 
at final concentration of 30 μg/mL of culture.
LPS-induced production of TNF-α and IL-10 by PBMC Figure 1
LPS-induced production of TNF-α and IL-10 by 
PBMC. This figure shows the kinetic of TNF-α and IL-10 
production by PBMC of six individuals chronically infected 
with S. mansoni stimulated in vitro with LPS (0.14 ng/mL).Microbial Cell Factories 2007, 6:1 http://www.microbialcellfactories.com/content/6/1/1
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coli to evaluate the in vitro immune response. As some
recombinant proteins have the ability to modulate the
immune response, they should be produced in a non-bac-
terial vector for future use as vaccines and treatments to
certain diseases.
Methods
Study population
Six individuals (4 male and 2 female) chronically infected
with S. mansoni living in an endemic area in Bahia, Brazil
were recruited. Patients were included in the study accord-
ing to the following criteria: any age or gender and
infected with S. mansoni.
S. mansoni proteins
The proteins were provided by the Institute of Biological
Science, Department of Biochemistry and Immunology,
UFMG, Brazil and they were tested for LPS contamination
using a commercially available LAL Chromogenic Kit. The
concentration of LPS found in these proteins was lower
than 0.25 ng/mL (Table 1).
The  S. mansoni antigens evaluated in this study were
Sm22.6, P24 and Sm14. Sm22.6 is a soluble protein from
the tegument, present in all life cycle of the worm with the
exception of egg [15]. The native form of the P24 is a frac-
tion of the PIII, an antigen obtained from Schistosoma
mansoni adult worm antigen (SWAP) [16], and Sm14 is a
Schistosoma mansoni antigen which belongs to the fatty
acid-binding protein family and was produced using the
pMal-c2 expression system as previously described [17].
The Ethical Committee of the Climério de Oliveira Hospi-
tal/Federal University of Bahia approved the present
study, and an informed consent was obtained from all
study participants or their legal guardians.
TNF-α production in PBMC cultures of individuals chronically infected with S. mansoni stimulated in vitro with S. mansoni  recombinant proteins in the presence or absence of Polymyxin B Figure 3
TNF-α production in PBMC cultures of individuals chronically infected with S. mansoni stimulated in vitro with 
S. mansoni recombinant proteins in the presence or absence of Polymyxin B. Figure 3A, B and C show TNF-α pro-
duction in cultures stimulated with rP24, rSm14 and rSm22.6, respectively. Recombinant proteins were used in the concentra-
tion of 10 μg/mL and Polymyxin B at final concentration of 30 μg/mL of culture.Microbial Cell Factories 2007, 6:1 http://www.microbialcellfactories.com/content/6/1/1
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Cell culture and cytokine measurement
Human peripheral blood mononuclear cells (PBMC)
were used to test the ability of PMB to neutralize the effect
of LPS itself and as contaminant of three different S. man-
soni recombinant proteins produced in E. coli in inducing
cytokine production. PBMC were obtained through the
Ficoll-Hypaque gradient and adjusted to a concentration
of 3 × 106 cells/ml in RPMI 1640 containing 10% of nor-
mal human serum (AB+, heat-inactivated), 100 U/mL
penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine,
30 mM HEPES (all from Life technologies GIBCO BRL,
Gaithersburg, MD). Cells were cultured in vitro in the pres-
ence or absence of Polymyxin B (10 μg/mL) and were
stimulated with LPS (0.14 ng/mL, which is the mean of
contaminant concentration in the cultures stimulated
with S. mansoni antigens), S. mansoni recombinant protein
rP24, rSm14, rSm22.6 (10 μg/mL) and with the mitogen
phytohemaglutinin (PHA) (2 μg/mL). Unstimulated cells
were also cultured as a control. Cultures were incubated at
37°C, 5% CO2 for 6, 12, 24 and 48 hours. After incuba-
tion, the supernatants were collected and maintained at -
20°C, for later measurement of cytokines. Levels of TNF-
α and IL-10 in culture supernatants were determined by
ELISA sandwich technique, using commercially available
kits (R&D Systems), and the results were expressed in
picograms per milliliter based on a standard curve.
Addition of polymyxin B to the cultures
Suspension of peripheral blood mononuclear cells (3 ×
106 cells/mL) were pre-incubated with Polymyxin B (CAL-
IL-10 production in PBMC cultures of individuals chronically infected with S. mansoni stimulated in vitro with S. mansoni recom- binant proteins in the presence or absence of Polymyxin B Figure 4
IL-10 production in PBMC cultures of individuals chronically infected with S. mansoni stimulated in vitro with S. 
mansoni recombinant proteins in the presence or absence of Polymyxin B. Figure 4A, B and C show IL-10 produc-
tion in cultures stimulated with rP24, rSm14 and rSm22.6, respectively. Recombinant proteins were used in the concentration 
of 10 μg/mL and Polymyxin B at final concentration of 30 μg/mL of culture.Microbial Cell Factories 2007, 6:1 http://www.microbialcellfactories.com/content/6/1/1
Page 6 of 6
(page number not for citation purposes)
BIOCHEM, Germany) in the concentration of 10 and 20
μg/mL for 30 minutes at 37°C, 5% CO2. They were then
incubated with the different recombinant proteins (10 μg/
mL) or LPS (0.14 ng/mL) and the cultures were incubated
for 6 to 48 hours as described above. Polymyxin B (10 or
20 μg/mL) was also added each 12 hours, during all cul-
ture period.
Statistical analysis
Wilcoxon matched pairs test were used to compare the
levels of TNF-α and IL-10 in supernatants of PBMC cul-
tures with or without Polymyxin B. Statistical significance
was established at the 95% confidence interval.
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